Clinicopathological characteristics | N | miR-155-3p expression | P | |
---|---|---|---|---|
Low expression | High expression | |||
(n  = 39) | (n  = 40) | |||
Age (years) | Â | Â | Â | 0.422 |
 < 10 | 62 | 29 | 33 |  |
 ≥ 10 | 17 | 10 | 7 |  |
Gender | Â | Â | Â | 0.494 |
 Male | 48 | 22 | 26 |  |
 Female | 31 | 17 | 14 |  |
Tumor site | Â | Â | Â | 0.344 |
 Cerebellar vermis | 53 | 24 | 29 |  |
 Cerebellar hemisphere | 26 | 15 | 11 |  |
Pathological type | Â | Â | Â | 0.031 |
 Classic type | 46 | 28 | 18 |  |
 Anaplastic/large cell type | 20 | 8 | 12 |  |
 Fibrogenic/nodular type | 13 | 3 | 10 |  |
Molecular subtype | Â | Â | Â | 0.005 |
 Wnt | 26 | 18 | 8 |  |
 SHH | 14 | 9 | 5 |  |
 Non-Wnt/SHH | 39 | 12 | 27 |  |
Metastatic status | Â | Â | Â | 0.261 |
 M0 | 43 | 24 | 19 |  |
 M1–3 | 36 | 15 | 21 |  |
Residual tumor size (cm2) | Â | Â | Â | 0.252 |
 ≤ 1.5 | 64 | 34 | 30 |  |
 > 1.5 | 15 | 5 | 10 |  |